Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
iNtRON Confirms Cancer-Controlling Effect of PHAGERIA® Drug Candidate in the Organoid Model
iNtRON Biotechnology has announced today that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a […]
Abacus Medicine Pharma Services and Laboratoires CTRS Extend Partnership to Improve Access to Orphacol® in Spain
Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce […]
FDA Grants Accelerated Approval for PADCEV® with KEYTRUDA for First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer
Seagen and Astellas Pharma have announced the United States Food and Drug Administration (FDA) has […]
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
After twenty years as one of the first personalized oncology companies, Indivumed today announced its […]
Gennova Biopharmaceuticals seeks Emergency Use Authorization in India for the First Needle-free mRNA Vaccine Omicron Booster
Following assessment of the primary endpoints of the Phase II/III study, PharmaJet partner Gennova Biopharmaceuticals […]
Heron Therapeutics Announces New CEO and Board Chairman
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
Evergreen Discovery, a leading radiopharmaceutical drug development company with a focus on the treatment and […]
Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month
Acorda Therapeutics today announced that it has launched an INBRIJA® (levodopa inhalation powder) television commercial […]
Vizgen Launches the MERSCOPE® PanNeuro Cell Type Predesigned Panel
Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics […]
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the FDA
Vertex Pharmaceuticals and CRISPR Therapeutics today announced the completion of the rolling Biologics License Applications […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more